List of Tables
    Table 1. Anti-epileptic Drugs for Pediatrics CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Anti-epileptic Drugs for Pediatrics Market Trends
    Table 3. Anti-epileptic Drugs for Pediatrics Market Drivers
    Table 4. Anti-epileptic Drugs for Pediatrics Market Challenges
    Table 5. Anti-epileptic Drugs for Pediatrics Market Restraints
    Table 6. Global Anti-epileptic Drugs for Pediatrics Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Anti-epileptic Drugs for Pediatrics Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Anti-epileptic Drugs for Pediatrics Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Anti-epileptic Drugs for Pediatrics Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Anti-epileptic Drugs for Pediatrics Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Anti-epileptic Drugs for Pediatrics Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Anti-epileptic Drugs for Pediatrics Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Anti-epileptic Drugs for Pediatrics Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Anti-epileptic Drugs for Pediatrics Sales Share by Manufacturer, 2017-2022
    Table 15. Global Anti-epileptic Drugs for Pediatrics Price by Manufacturer (2017-2022) & (USD/Unit)
    Table 16. Global Anti-epileptic Drugs for Pediatrics Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Anti-epileptic Drugs for Pediatrics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-epileptic Drugs for Pediatrics as of 2021)
    Table 18. Top Players of Anti-epileptic Drugs for Pediatrics in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Anti-epileptic Drugs for Pediatrics Product Type
    Table 20. Date of International Manufacturers Enter into Anti-epileptic Drugs for Pediatrics Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Anti-epileptic Drugs for Pediatrics Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Anti-epileptic Drugs for Pediatrics Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Anti-epileptic Drugs for Pediatrics Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Anti-epileptic Drugs for Pediatrics Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Anti-epileptic Drugs for Pediatrics Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Anti-epileptic Drugs for Pediatrics Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Anti-epileptic Drugs for Pediatrics Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Anti-epileptic Drugs for Pediatrics Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Anti-epileptic Drugs for Pediatrics Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Anti-epileptic Drugs for Pediatrics Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Anti-epileptic Drugs for Pediatrics Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Anti-epileptic Drugs for Pediatrics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Anti-epileptic Drugs for Pediatrics Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Anti-epileptic Drugs for Pediatrics Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Anti-epileptic Drugs for Pediatrics Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Anti-epileptic Drugs for Pediatrics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Anti-epileptic Drugs for Pediatrics Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Anti-epileptic Drugs for Pediatrics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Anti-epileptic Drugs for Pediatrics Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Anti-epileptic Drugs for Pediatrics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Mylan N.V Corporation Information
    Table 43. Mylan N.V Description and Business Overview
    Table 44. Mylan N.V Anti-epileptic Drugs for Pediatrics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 45. Mylan N.V Anti-epileptic Drugs for Pediatrics Product
    Table 46. Mylan N.V Recent Development
    Table 47. Cephalon, Inc Corporation Information
    Table 48. Cephalon, Inc Description and Business Overview
    Table 49. Cephalon, Inc Anti-epileptic Drugs for Pediatrics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 50. Cephalon, Inc Product
    Table 51. Cephalon, Inc Recent Development
    Table 52. GlaxoSmithKline plc Corporation Information
    Table 53. GlaxoSmithKline plc Description and Business Overview
    Table 54. GlaxoSmithKline plc Anti-epileptic Drugs for Pediatrics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 55. GlaxoSmithKline plc Product
    Table 56. GlaxoSmithKline plc Recent Development
    Table 57. Janssen Pharmaceuticals Corporation Information
    Table 58. Janssen Pharmaceuticals Description and Business Overview
    Table 59. Janssen Pharmaceuticals Anti-epileptic Drugs for Pediatrics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 60. Janssen Pharmaceuticals Product
    Table 61. Janssen Pharmaceuticals Recent Development
    Table 62. Novartis AG Corporation Information
    Table 63. Novartis AG Description and Business Overview
    Table 64. Novartis AG Anti-epileptic Drugs for Pediatrics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 65. Novartis AG Product
    Table 66. Novartis AG Recent Development
    Table 67. Pfizer, Inc Corporation Information
    Table 68. Pfizer, Inc Description and Business Overview
    Table 69. Pfizer, Inc Anti-epileptic Drugs for Pediatrics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 70. Pfizer, Inc Product
    Table 71. Pfizer, Inc Recent Development
    Table 72. Sanofi S.A Corporation Information
    Table 73. Sanofi S.A Description and Business Overview
    Table 74. Sanofi S.A Anti-epileptic Drugs for Pediatrics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 75. Sanofi S.A Product
    Table 76. Sanofi S.A Recent Development
    Table 77. UCB Pharma Limited Corporation Information
    Table 78. UCB Pharma Limited Description and Business Overview
    Table 79. UCB Pharma Limited Anti-epileptic Drugs for Pediatrics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 80. UCB Pharma Limited Product
    Table 81. UCB Pharma Limited Recent Development
    Table 82. Sunovion Pharmaceuticals Limited Corporation Information
    Table 83. Sunovion Pharmaceuticals Limited Description and Business Overview
    Table 84. Sunovion Pharmaceuticals Limited Anti-epileptic Drugs for Pediatrics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 85. Sunovion Pharmaceuticals Limited Product
    Table 86. Sunovion Pharmaceuticals Limited Recent Development
    Table 87. Valeant Pharmaceuticals International, Inc Corporation Information
    Table 88. Valeant Pharmaceuticals International, Inc Description and Business Overview
    Table 89. Valeant Pharmaceuticals International, Inc Anti-epileptic Drugs for Pediatrics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 90. Valeant Pharmaceuticals International, Inc Product
    Table 91. Valeant Pharmaceuticals International, Inc Recent Development
    Table 92. Zogenix Corporation Information
    Table 93. Zogenix Description and Business Overview
    Table 94. Zogenix Anti-epileptic Drugs for Pediatrics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 95. Zogenix Product
    Table 96. Zogenix Recent Development
    Table 97. GW Pharmaceuticals Corporation Information
    Table 98. GW Pharmaceuticals Description and Business Overview
    Table 99. GW Pharmaceuticals Anti-epileptic Drugs for Pediatrics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 100. GW Pharmaceuticals Product
    Table 101. GW Pharmaceuticals Recent Development
    Table 102. Insys Corporation Information
    Table 103. Insys Description and Business Overview
    Table 104. Insys Anti-epileptic Drugs for Pediatrics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 105. Insys Product
    Table 106. Insys Recent Development
    Table 107. Zynerba Corporation Information
    Table 108. Zynerba Description and Business Overview
    Table 109. Zynerba Anti-epileptic Drugs for Pediatrics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 110. Zynerba Product
    Table 111. Zynerba Recent Development
    Table 112. Key Raw Materials Lists
    Table 113. Raw Materials Key Suppliers Lists
    Table 114. Anti-epileptic Drugs for Pediatrics Customers List
    Table 115. Anti-epileptic Drugs for Pediatrics Distributors List
    Table 116. Research Programs/Design for This Report
    Table 117. Key Data Information from Secondary Sources
    Table 118. Key Data Information from Primary Sources
List of Figures
    Figure 1. Anti-epileptic Drugs for Pediatrics Product Picture
    Figure 2. Global Anti-epileptic Drugs for Pediatrics Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Anti-epileptic Drugs for Pediatrics Market Size 2017-2028 (US$ Million)
    Figure 4. Global Anti-epileptic Drugs for Pediatrics Sales 2017-2028 (K Units)
    Figure 5. United States Anti-epileptic Drugs for Pediatrics Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Anti-epileptic Drugs for Pediatrics Market Size 2017-2028 (US$ Million)
    Figure 7. United States Anti-epileptic Drugs for Pediatrics Sales 2017-2028 (K Units)
    Figure 8. United States Anti-epileptic Drugs for Pediatrics Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Anti-epileptic Drugs for Pediatrics Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Anti-epileptic Drugs for Pediatrics Report Years Considered
    Figure 11. Product Picture of 1st Generation
    Figure 12. Product Picture of 2nd Generation
    Figure 13. Product Picture of 3rd Generation
    Figure 14. Global Anti-epileptic Drugs for Pediatrics Market Share by Type in 2022 & 2028
    Figure 15. Global Anti-epileptic Drugs for Pediatrics Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 16. Global Anti-epileptic Drugs for Pediatrics Sales Market Share in Value by Type (2017-2028)
    Figure 17. Global Anti-epileptic Drugs for Pediatrics Sales by Type (2017-2028) & (K Units)
    Figure 18. Global Anti-epileptic Drugs for Pediatrics Sales Market Share in Volume by Type (2017-2028)
    Figure 19. Global Anti-epileptic Drugs for Pediatrics Price by Type (2017-2028) & (USD/Unit)
    Figure 20. United States Anti-epileptic Drugs for Pediatrics Market Share by Type in 2022 & 2028
    Figure 21. United States Anti-epileptic Drugs for Pediatrics Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 22. United States Anti-epileptic Drugs for Pediatrics Sales Market Share in Value by Type (2017-2028)
    Figure 23. United States Anti-epileptic Drugs for Pediatrics Sales by Type (2017-2028) & (K Units)
    Figure 24. United States Anti-epileptic Drugs for Pediatrics Sales Market Share in Volume by Type (2017-2028)
    Figure 25. United States Anti-epileptic Drugs for Pediatrics Price by Type (2017-2028) & (USD/Unit)
    Figure 26. Product Picture of Hospitals
    Figure 27. Product Picture of Retail Pharmacies
    Figure 28. Product Picture of Online Pharmacies
    Figure 29. Global Anti-epileptic Drugs for Pediatrics Market Share by Application in 2022 & 2028
    Figure 30. Global Anti-epileptic Drugs for Pediatrics Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 31. Global Anti-epileptic Drugs for Pediatrics Sales Market Share in Value by Application (2017-2028)
    Figure 32. Global Anti-epileptic Drugs for Pediatrics Sales by Application (2017-2028) & (K Units)
    Figure 33. Global Anti-epileptic Drugs for Pediatrics Sales Market Share in Volume by Application (2017-2028)
    Figure 34. Global Anti-epileptic Drugs for Pediatrics Price by Application (2017-2028) & (USD/Unit)
    Figure 35. United States Anti-epileptic Drugs for Pediatrics Market Share by Application in 2022 & 2028
    Figure 36. United States Anti-epileptic Drugs for Pediatrics Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 37. United States Anti-epileptic Drugs for Pediatrics Sales Market Share in Value by Application (2017-2028)
    Figure 38. United States Anti-epileptic Drugs for Pediatrics Sales by Application (2017-2028) & (K Units)
    Figure 39. United States Anti-epileptic Drugs for Pediatrics Sales Market Share in Volume by Application (2017-2028)
    Figure 40. United States Anti-epileptic Drugs for Pediatrics Price by Application (2017-2028) & (USD/Unit)
    Figure 41. North America Anti-epileptic Drugs for Pediatrics Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 42. North America Anti-epileptic Drugs for Pediatrics Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 43. U.S. Anti-epileptic Drugs for Pediatrics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Canada Anti-epileptic Drugs for Pediatrics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Europe Anti-epileptic Drugs for Pediatrics Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 46. Europe Anti-epileptic Drugs for Pediatrics Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 47. Germany Anti-epileptic Drugs for Pediatrics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. France Anti-epileptic Drugs for Pediatrics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. U.K. Anti-epileptic Drugs for Pediatrics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Italy Anti-epileptic Drugs for Pediatrics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Russia Anti-epileptic Drugs for Pediatrics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Asia-Pacific Anti-epileptic Drugs for Pediatrics Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 53. Asia-Pacific Anti-epileptic Drugs for Pediatrics Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 54. China Anti-epileptic Drugs for Pediatrics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Japan Anti-epileptic Drugs for Pediatrics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. South Korea Anti-epileptic Drugs for Pediatrics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. India Anti-epileptic Drugs for Pediatrics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Australia Anti-epileptic Drugs for Pediatrics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Taiwan Anti-epileptic Drugs for Pediatrics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Indonesia Anti-epileptic Drugs for Pediatrics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Thailand Anti-epileptic Drugs for Pediatrics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Malaysia Anti-epileptic Drugs for Pediatrics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Philippines Anti-epileptic Drugs for Pediatrics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Latin America Anti-epileptic Drugs for Pediatrics Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 65. Latin America Anti-epileptic Drugs for Pediatrics Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 66. Mexico Anti-epileptic Drugs for Pediatrics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Brazil Anti-epileptic Drugs for Pediatrics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Argentina Anti-epileptic Drugs for Pediatrics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Middle East & Africa Anti-epileptic Drugs for Pediatrics Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 70. Middle East & Africa Anti-epileptic Drugs for Pediatrics Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 71. Turkey Anti-epileptic Drugs for Pediatrics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Saudi Arabia Anti-epileptic Drugs for Pediatrics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. U.A.E Anti-epileptic Drugs for Pediatrics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Anti-epileptic Drugs for Pediatrics Value Chain
    Figure 75. Anti-epileptic Drugs for Pediatrics Production Process
    Figure 76. Channels of Distribution
    Figure 77. Distributors Profiles
    Figure 78. Bottom-up and Top-down Approaches for This Report
    Figure 79. Data Triangulation
    Figure 80. Key Executives Interviewed